Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families

N Engl J Med. 1983 Aug 11;309(6):340-4. doi: 10.1056/NEJM198308113090604.

Abstract

Protein C is the zymogen of a vitamin K-dependent serine protease involved in blood coagulation. In the absence of protein C the inactivation of activated factors V and VIIIC is impaired, and the fibrinolytic capacity of the circulating blood is reduced. These conditions promote excessive fibrin formation and thus constitute a risk factor for thrombosis. Using an immunologic assay for protein C, we identified 18 patients (11 male and 7 female) in three unrelated Dutch families as fulfilling the criteria for an isolated protein C deficiency. In 12 patients who were not receiving oral anticoagulant treatment the mean protein C antigen concentration was 0.48 +/- 0.09 U per milliliter (+/- S.D.), and in 6 patients who were receiving adjusted doses of oral anticoagulants and had stable anticoagulation, the mean value was 0.17 +/- 0.05 U per milliliter. (The value in healthy subjects is 0.98 +/- 0.19 U per milliliter.) Fourteen of the 18 patients had a history of venous thromboembolism, with superficial thrombophlebitis as the hallmark of this condition (in 13 patients). These data are consistent with an autosomal dominant trait with variable expressivity.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Coagulation Disorders*
  • Blood Coagulation Tests
  • Female
  • Glycoproteins / deficiency*
  • Humans
  • Male
  • Middle Aged
  • Netherlands
  • Pedigree
  • Protein C
  • Risk
  • Thromboembolism / blood
  • Thromboembolism / etiology
  • Thromboembolism / genetics*
  • Thrombophlebitis / blood
  • Thrombophlebitis / etiology
  • Thrombophlebitis / genetics*

Substances

  • Glycoproteins
  • Protein C